Replies to post #652687 on ORIONS Money Stocks

[Viewmont]

$CDT

$CDT Active pre-market.
Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 targeting autoimmune indications and myeloperoxidase inhibitor AZD5904 targeting idiopathic male infertility

— Viewmont (@viewmont12) August 8, 2024

Gave you member follow #124.